CHOSEN Raises $5 Mn Series A to Advance Science-Driven Skincare for Indian Consumers

Chennai-based D2C skincare brand CHOSEN has raised $5 million in a Series A funding round, led by Fireside Ventures, with participation from BOLD, Alkemi Growth Capital, and a group of dermatologist-angel investors. This funding marks a significant step forward in CHOSEN’s mission to deliver evidence-based skincare tailored for Indian consumers.

Founded by Dr. Renita Rajan, CHOSEN focuses on science-backed, clinically validated skincare solutions specifically designed for melanin-rich Indian skin. In a market often dominated by generic or globally adapted products, the brand stands out by addressing the unique dermatological needs of Indian consumers through research-driven formulations.

The newly raised capital will be utilized to strengthen research and development, expand its pipeline of clinically tested products, and scale its dermatologist-led Centre of Excellence. Additionally, the company plans to invest in talent acquisition across key functions to support its next phase of growth.

CHOSEN offers a range of topical treatments and nutraceutical products, all developed under the guidance of dermatology experts. One of its strongest differentiators is its extensive clinical data repository, which is among the largest in Indian dermatology. This data-driven approach enables the company to continuously refine its formulations and deliver highly effective skincare solutions.

The investment from global and domestic players, including the corporate venture arm of L’Oréal, highlights growing confidence in India’s clinically-led beauty and personal care segment. As consumers increasingly seek transparency, efficacy, and personalization, brands like CHOSEN are well-positioned to capture this demand.

India’s skincare market is witnessing a shift from traditional beauty products to science-backed, dermatology-focused solutions. CHOSEN’s emphasis on clinical validation, combined with its focus on melanin-rich skin, gives it a strong edge in this evolving landscape.

With this funding milestone, CHOSEN aims to deepen its position as a specialist brand and expand its reach across India and beyond. By blending clinical expertise with innovation, the company is redefining skincare standards and setting a new benchmark for effectiveness and trust.

As the demand for personalized and evidence-based skincare continues to rise, CHOSEN is poised to play a key role in shaping the future of dermatology-driven beauty in India.